Skip to main content
Bildspel: 

Duane Reade to begin carrying Kerasal Nail in New York City pharmacies

Moberg Pharma North America has begun shipping Kerasal Nail to 250 Duane Reade pharmacy and convenience stores in New York City.

Through its U.S. subsidiary, Moberg Pharma North America, Moberg Derma has begun shipping Kerasal Nail to New York City chain Duane Reade.  Duane Reade Inc. is a subsidiary of the Walgreen Company, a chain of approximately 250 pharmacy and convenience stores, primarily located in New York City.  Duane Reade’s parent company, Walgreens already sells Kerasal Nail in over 7,000 drug stores since last year.

About Moberg Pharma
Moberg Pharma AB (publ) is a rapidly growing Swedish pharmaceutical company with direct sales through its own sales organization in the US and sales through distributors in more than 35 countries. The company’s product portfolio includes topical products for the treatment of skin disorders and pain under the brands Kerasal®, Jointflex®, Kerasal Nail® and Kaprolac®. Kerasal Nail® (Nalox™ in many markets) is the leading product for the treatment of nail disorders in the Nordic market. The portfolio is developed further through acquisitions and in-licensing of products as well as product development with focus on innovative drug delivery based on proven compounds. Moberg Pharma has offices in Stockholm and New Jersey and the company’s share (OMX: MOB) is listed on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. For further information, please visit: www.mobergpharma.se